Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA
5 clinical trials · Condition
◉ Watch Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA
| Record | Firm | Date |
|---|---|---|
| Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT01132586) | National Cancer Institute (NCI) | 2010-05-01 |
| Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia (NCT00313586) | National Cancer Institute (NCI) | 2006-08-01 |
| Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases (NCT00351975) | National Cancer Institute (NCI) | 2006-06-01 |
| Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia (NCT00217646) | National Cancer Institute (NCI) | 2005-10-01 |
| Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00105001) | Fred Hutchinson Cancer Center | 2004-11-01 |
Track Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA automatically
Every clearance here is in the API, with alerts when new ones post.